BMO Capital Downgrades BioMed Realty (BMR) to Market Perform, Cuts Price Target to $19

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. BABA
10. OSIS

January 3, 2012 11:44 AM EST
Get Alerts BMR Hot Sheet
Price: $1.31 +2.34%

Rating Summary:
    6 Buy, 8 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
BMO Capital downgraded shares of BioMed Realty (NYSE: BMR) to a Market Perform rating from its previous rating of Outperform. The firm also reduced its price target from $22 to $19 on the shares.

For an analyst ratings summary and ratings history on BioMed Realty click here. For more ratings news on BioMed Realty click here.

Shares of BioMed Realty closed at $18.08 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

BMO Capital